𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Normal dopamine transporter SPECT in neuropathologically confirmed corticobasal degeneration

✍ Scribed by Valtteri Kaasinen, Maria Gardberg, Matias Röyttä, Marko Seppänen…

Book ID
120898548
Publisher
Springer
Year
2013
Tongue
English
Weight
216 KB
Volume
260
Category
Article
ISSN
0340-5354

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Dopamine transporters, D2 receptors, and
Dopamine transporters, D2 receptors, and glucose metabolism in corticobasal degeneration
✍ Stefanie Klaffke; Andrea A. Kuhn; Michail Plotkin; Holger Amthauer; Daniel Harna 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 59 KB

## Abstract Alterations in presynaptic and postsynaptic dopaminergic system and cerebral glucose metabolism in corticobasal degeneration (CBD) were assessed to evaluate the potential usefulness of different imaging methods for CBD. ^123^I‐FP‐CIT/^123^I‐β‐CIT SPECT and ^123^I‐IBZM SPECT as well as ^

Patterns of regional cerebral blood flow
Patterns of regional cerebral blood flow in corticobasal degeneration studied using HMPAO SPECT; comparison with Parkinson's disease and normal controls
✍ Dr. H. S. Markus; A. J. Lees; G. Lennox; C. D. Marsden; D. C. Costa 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 867 KB

## Abstract Corticobasal degeneration (CBD) is a rare syndrome characterised by an asymmetrical rigidity with localised cortical signs, particularly apraxia. Using positron emission tomography, abnormal patterns of cortical metabolism have recently been shown. We have studied patterns of regional c

Altropane, a SPECT or PET imaging probe
Altropane, a SPECT or PET imaging probe for dopamine neurons: III. Human dopamine transporter in postmortem normal and Parkinson's diseased brain
✍ Bertha K. Madras; Lawrence M. Gracz; Michele A. Fahey; David Elmaleh; Peter C. M 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 362 KB 👁 2 views

Increasing evidence suggests that the dopamine transporter is situated almost exclusively on dopamine neurons. Accordingly, it is an valuable marker for Parkinson's disease and other pathological states of dopamine neurons. We previously demonstrated that the potent dopamine transport inhibitor [ 12